Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions

References

• Bradford JM, Pawlak A. 1993a. Double-blind crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav22:383–402.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1993b. Effects of cyproterone acetate on sexual arousal patterns of pedophiles. Arch Sex Behav22: 629–641.
   PubMed Web of Science ®Google Scholar
• Bradford JM. 2001. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior. Can J Psychiatry46:26–34.
   PubMed Web of Science ®Google Scholar
• Briken P, Hill A, Berner W. 2003. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: A systematic review. J Clin Psychiatry64:890–897.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovovsky Z. 1992. The effect of cyproterone acetate on sleeping and waking penile erections in pedophiles: Possible implication for treatment. Can J Psychiatry37:33–39.
   PubMed Web of Science ®Google Scholar
• Emory LE, Cole CM, Meyer WJ. 1992. The Texas experience with depo-Provera: 1980–1990. J Offender Rehabil18:125–139.
   Google Scholar
• Fedoroff JP. 1995. Antiandrogens vs. serotonergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sex4:111–122.
   Google Scholar
• Fedoroff JP. 2011. The pharmacological treatment of paraphilic sexual disorders. Am Acad Psychiatry Law Newsletter36: 21–22.
   Google Scholar
• Freund K, Watson R. 1991. Assessment of the sensitivity and specificity of a phallometric test: an update of phallometric diagnosis of pedophilia. Psychol Assess3:254–260.
   Google Scholar
• Gooren LJ. 2011. Clinical review: ethical and medical considerations of androgen deprivation treatment of sex offenders. J Clin Endocrinol Metab96:3628–3637.
   PubMed Web of Science ®Google Scholar
• Grasswick LJ, Bradford JM. 2003. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports. J Forensic Sci48:849–855.
   PubMed Web of Science ®Google Scholar
• Guay DRP. 2009. Drug treatment of paraphilic and nonparaphilic sexual disorders. Clin Ther31:1–31.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Bussière MT. 1998. Predicting relapse: a meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol66:348–362.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Harris AJR, Scott TL, Helmus L. 2007. Assessing the risk of sexual offenders on community supervision: The Dynamic Supervision Project. Ottawa: Public safety and Emergency Preparedness Canada.
   Google Scholar
• Hanson RK, Morton-Bourgon KE. 2005. The Characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol73:1154–1163.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Thornton D. 1999. Static-99: Improving actuarial risk assessments for sex offenders. Ottawa: Department of the Solicitor General of Canada.
   Google Scholar
• Harris G, Rice M, Quinsey V. 1993. Violent recidivism of mentally disordered offenders: the development of a statistical prediction instrument. Crim Justice Behav20:3–15.
   Web of Science ®Google Scholar
• Hoogeveen J, Van der Veer E. 2008. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia. J Sex Med5:626–630.
   PubMed Web of Science ®Google Scholar
• Jordan K, Fromberger P, Stolpman G, Müller JL. 2011. The role of testosterone in sexuality and paraphilia – A neurobiological approach. Part II: testosterone and paraphilia. J Sex Med8:3008–3029.
   PubMed Web of Science ®Google Scholar
• Langevin R, Wright P, Handy L. 1988. What do sex offenders want? Ann Sex Res1:363–385.
   Google Scholar
• Maletzky BM. 1991. The use of medroxyprogesterone acetate to assist in the treatment of sexual offenders. Ann Sex Res4: 117–129.
   Google Scholar
• Maletzky BM. 1993. Factors associated with success and failure in the behavioral and cognitive treatment of sexual offenders. Ann Sex Res6:241–258.
   Google Scholar
• Maletzky BM, Field G. 2003. The biological treatment of dangerous sexual offenders, a review and preliminary report of the Oregon pilot depo-Provera program. Aggress Violent Behav8:391–412.
   Web of Science ®Google Scholar
• Maletzky BM, Tolan A, McFarland B. 2006. The Oregon depo-Provera program: a five year follow-up. Sex Abuse18:303–316.
   PubMed Web of Science ®Google Scholar
• Müller-Isberner R, Eucker S. 2009. Unterbringung im Maßregelvollzug gem. §63 StGB. In: Foerster K, Dressing H, editors. Psychiatrische Begutachtung. München: Elsevier. p. 411–469.
   Google Scholar
• Prentky RA. 1997. Arousal reduction in sexual offenders: a review of antiandrogen interventions. Sex Abuse9:335–347.
   Google Scholar
• Rösler A, Witztum E. 1998. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New Engl J Med338:416–422.
   PubMed Web of Science ®Google Scholar
• Rösler A, Witztum E. 2000. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law18:43–56.
   PubMed Web of Science ®Google Scholar
• Saleem R, Kaitiff D, Treasaden I, Vermeulen J. 2011. Clinical experience of the use of triptorelin as an antilibidinal medication in a high-security hospital. J Forensic Psychiatry Psychol22:243–251.
   Web of Science ®Google Scholar
• Safarinejad MR. 2008. Treatment of nonparaphilic hypersexuality in men with a long-acting analog of gonadotropin-releasing hormone. J Sex Med6:1151–1164.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Gizewski E, Kruger T. 2009. Reduced neuronal responsiveness to visual stimuli in a pedophile treated with a long-acting LH-RH agonist. J Sex Med6:892–894.
   PubMed Web of Science ®Google Scholar
• Seto MC, Lalumiére ML, Kuban M. 1999. The sexual preferences of incest offenders. J Abnorm Psychol108:267–272.
   PubMed Web of Science ®Google Scholar
• Seto MC, Lalumiére ML. 2001. A brief screening scale to identify pedophilic interests among child sexual abusers. Sex Abuse13: 5–25.
   Google Scholar
• Statistisches Bundesamt. 2012. Rechtspflege. Strafvollzug – Demographische und kriminologische Merkmale der Strafgefangenen zum Stichtag 31.3. Wiesbaden: Statistisches Bundesamt.
   Google Scholar
• Stolpmann G. 2010. Psychiatrische Maßregelbehandlung. Aus Politik und Zeitgeschichte7:28–33.
   Google Scholar
• Thibaut F, Barra FDL, Gordon H, Cosyns P, Bradford JMW. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias. World J Biol Psychiatry11:604–655.
   PubMed Web of Science ®Google Scholar
• Turner D, Basdekis-Jozsa R, Briken P. (2013). The prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions. J Sex Med10: 570–578.
   PubMed Web of Science ®Google Scholar